Keil, L.; Chevalier, C.; Kirchhof, P.; Blankenberg, S.; Lund, G.; Müllerleile, K.; Magnussen, C.
CMR-Based Risk Stratification of Sudden Cardiac Death and Use of Implantable Cardioverter–Defibrillator in Non-Ischemic Cardiomyopathy. Int. J. Mol. Sci. 2021, 22, 7115.
https://doi.org/10.3390/ijms22137115
AMA Style
Keil L, Chevalier C, Kirchhof P, Blankenberg S, Lund G, Müllerleile K, Magnussen C.
CMR-Based Risk Stratification of Sudden Cardiac Death and Use of Implantable Cardioverter–Defibrillator in Non-Ischemic Cardiomyopathy. International Journal of Molecular Sciences. 2021; 22(13):7115.
https://doi.org/10.3390/ijms22137115
Chicago/Turabian Style
Keil, Laura, Céleste Chevalier, Paulus Kirchhof, Stefan Blankenberg, Gunnar Lund, Kai Müllerleile, and Christina Magnussen.
2021. "CMR-Based Risk Stratification of Sudden Cardiac Death and Use of Implantable Cardioverter–Defibrillator in Non-Ischemic Cardiomyopathy" International Journal of Molecular Sciences 22, no. 13: 7115.
https://doi.org/10.3390/ijms22137115
APA Style
Keil, L., Chevalier, C., Kirchhof, P., Blankenberg, S., Lund, G., Müllerleile, K., & Magnussen, C.
(2021). CMR-Based Risk Stratification of Sudden Cardiac Death and Use of Implantable Cardioverter–Defibrillator in Non-Ischemic Cardiomyopathy. International Journal of Molecular Sciences, 22(13), 7115.
https://doi.org/10.3390/ijms22137115